Hypothesis: Interval reevaluation for resectability of hepatic colorectal m
etastases aids patient selection.
Design: A retrospective review. Setting: A tertiary care medical center.
Patients and Methods: From January 1, 1985, to July 1, 1998, 318 patients w
ith colorectal hepatic metastases were identified. Resectable lesions (N =
73) were divided into synchronous (n = 36) or metachronous (n = 37) and ret
rospectively reviewed for immediate resection or interval revaluation. Kapl
an-Meier survival curves of treatment groups were compared by the log-rank
test.
Results: Survival curves of patients with synchronous and metachronous lesi
ons undergoing interval reevaluation vs immediate resection were not signif
icantly different (P = .74 and P = .65, respectively). No lesions from pati
ents who underwent interval reevaluation became unresectable due to growth
of the initial metastases. After interval reevaluation, 8 (29%) of 28 patie
nts with synchronous metastases were spared the morbidity of laparotomy bec
ause of distant or an increased number of metastases and (36%;) of 28 patie
nts were spared the morbidity of hepatic resection at the time of internal
laparotomy. Actuarial median and 5-year survival of patients after delayed
hepatic resection (51 months and 45%, respectively) were significantly impr
oved compared with those of all other patients with respectable metastases
(23 months and 7%, respectively) (P = .02). For patients with metachronous
lesions who underwent interval reevaluation, 4 (29%) of 14 patients were sp
ared the morbidity of laparotomy because of an increased number of hepatic
or distant metastases.
Conclusions: Delaying hepatic resection for metastatic colorectal cancer do
es not impair survival. Potentially, two thirds of patients can avoid major
hepatic surgery. For synchronous metastases. delaying hepatic resection ap
pears to select patients who will benefit from hepatic resection.